|

LN-145/LN-144 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Iovance Biotherapeutics, Inc.1

Indications

  • Primary Central Nervous System Carcinoma1
  • Soft Tissue Sarcoma1
  • Rhabdomyosarcoma1
  • Ewing Sarcoma1
  • Melanoma1

Aurora, Colorado1 trial

Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants

Children's Hospital of Colorado

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.